| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |